Charles River Laboratorie (CRL) Misses Q2 EPS by 1c; Extends Agreement with AstraZeneca (AZN)
Go back to Charles River Laboratorie (CRL) Misses Q2 EPS by 1c; Extends Agreement with AstraZeneca (AZN)| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,503,826 | |||||
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 186.60 +5.04 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $181.56 | 52 Week High | $89.18 | |||
| Open | $182.21 | 52 Week Low | $65.70 | |||
| Day High | $187.64 | P/E | 86.79 | |||
| Day Low | $181.53 | EPS | $2.15 | |||
| Volume | 639,949 | |||||
